[Retracted] Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation

<div>The tumor growth of mice of lung cancer subcutaneously transplanted tumor. (a) The xenograft tumor growth of each group: metformin, PD-L1 MAb, metformin + PD-L1 MAb and Control. The mice body weight (b) and xenograft tumor volume (c) was quantified (<i>n</i> = 6).</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: [Retracted] Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation 

Figure 1 | [Retracted] Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation 